Objetivo
The QuIC-ConCePT consortium has 2 objectives:
1.(90% of resource, WP2-5) to qualify 3 specific imaging biomarkers (IBs) of tumour cell proliferation, apoptosis, and necrosis, to allow drug developers to demonstrate reliably modulation of these pathologic processes in tumours in patients in realistic trials. Our vision for January 2016 is that drug developers can incorporate these IBs for decision-making in Phase I trials of investigational therapies, confident that the IBs are technically valid, that a measured change in the IB faithfully reflects the desired change in the underlying tumour pathology, and that the IBs can be readily deployed in multiple cancer centres in a robust, consistent, ethical, and cost-effective way acceptable to patients.
2.(10% of resource, WP6) includes a portfolio of innovative approaches to devise, evaluate and introduce IBs of invasion and metastasis.
The IBs of tumour cell proliferation and necrosis will be developed respectively from FLT PET and ADC MRI respectively. Initial apoptosis plans focus on ICMT11 PET, possibly with other IBs introduced later. The project will be delivered using a portfolio of animal (WP2), human (WP3), image analysis (WP4) and regulatory (WP5) work. The project will be coordinated and the interdependent workpackages integrated in WP1. These WPs will deliver image acquisition and analysis protocols which are technically valid, standardised and suitable for multicentre use. We will evaluate reproducibility, effects of intervention, timing, dose-response, and imaging-histopathology correlation in animals and patients. The project is timely, and highly likely to deliver IBs which will markedly improve drug development, and benefit cancer patients in Europe and globally. The managing entity (EORTC) is already world-leading in the qualification of IBs, and the consortium includes in the academic and EFPIA partners some of the world's most productive and innovative physicians and scientists in cancer imaging.
Ámbito científico
Convocatoria de propuestas
IMI-JU-02-2009
Consulte otros proyectos de esta convocatoria
Régimen de financiación
JTI-CP-IMI - Joint Technology Initiatives - Collaborative Project (IMI)Coordinador
1200 Bruxelles / Brussel
Bélgica
Ver en el mapa
Participantes (23)
151 85 Sodertaelje
Ver en el mapa
La participación finalizó
E20 1JQ LONDON
Ver en el mapa
M13 9PL Manchester
Ver en el mapa
48149 MUENSTER
Ver en el mapa
6525 XZ Nijmegen
Ver en el mapa
75654 Paris
Ver en el mapa
6229 ET Maastricht
Ver en el mapa
1081 HV Amsterdam
Ver en el mapa
WC2R 2LS London
Ver en el mapa
2650 Edegem
Ver en el mapa
SW7 3RP London
Ver en el mapa
3015 GD Rotterdam
Ver en el mapa
SW7 2AZ LONDON
Ver en el mapa
44815 Saint-Herblain
Ver en el mapa
8092 Zuerich
Ver en el mapa
1831 Diegem
Ver en el mapa
RG21 4FA Basingstoke
Ver en el mapa
TW89GS Brentford
Ver en el mapa
64293 Darmstadt
Ver en el mapa
CT13 9NJ Sandwich
Ver en el mapa
4070 Basel
Ver en el mapa
94250 GENTILLY
Ver en el mapa
CB2 1TN Cambridge
Ver en el mapa